Thomas Filleron

Semi-parametric modelling for analysing the evolution of toxicities over time

In oncology clinical research, reporting adverse events (AEs) is absolutely essential to depict the toxicity profile of new therapeutics such as targeted therapies or immunotherapies. However, conventional methods of analysis are unable to capture the new patterns of AEs induced...